the EVA study "Etude du Vieillissement Artériel" (n=589, 73.5  3 years).
Introduction
Among the leading causes of cognitive impairment, an increase in brain oxidative stress is well documented (1) . In fact, the brain is particularly prone to free radical attacks owing to its relatively low antioxidants content, a considerable amount of polyunsaturated fatty acid chains in the neuronal membrane lipids and its high oxygen consumption rate (2) .
The hypothesis of carotenoids having a preventive role in cognitive impairment is suggested by their ability to trap peroxyl radicals and their singlet oxygen quenching properties, which enables them to prevent lipid peroxidation (3, 4) . Epidemiological studies (5) (6) (7) (8) (9) and clinical trials (10, 11) on cognitive impairment and plasma carotenoids mainly concern β-carotene, which is a major carotenoid. But some biological studies showed that antioxidant activity of other carotenoids could be more effective than β-carotene activity (12, 13) . This study's aim is to examine the relationship between cognitive performances and a large variety of carotenoids including xanthophylls (lutein, zeaxanthin, β-cryptoxanthin) and carotenes (lycopene, α-carotene, transβ-carotene and cisβ-carotene) in a healthy elderly population.
Materiel and methods

Study population
The EVA study ("Etude du Vieillissement Artériel") is a nine-year longitudinal study with 6 waves of follow-up (14) . During the first two years 1991-1993 (EVA0), 1389 volunteers (574 men and 815 women) born between 1922 and 1932 (mean age = 65) residing in the town of Nantes (Western France) were recruited from electoral rolls, and to a lesser extent, via information campaigns. The sixth and last follow-up of the EVA study (EVA6) was conducted between June 2000 and December 2001. During the 9-year follow-up, one hundred and one deaths occurred. Cancer was the first leading cause of death (n=45, 44.5%), the second one was cardiovascular diseases (n=22, 21.8%). The main factors related to mortality were found to be, as reported in the literature: male gender, smoking (current and ex-), alcohol intake, medication use, obesity, diabetes, hypertension and cardiovascular diseases (15) . At EVA6, the blood samplings after a 12-hour fast were obtained for 773 subjects. Subjects who did not completed the whole study (n=616, 44.3%) were significantly more frequently men (those who not completed: 44.3% vs. those who completed: 38.9%, p=0.04)), obese or overweight subjects (57.9% vs. 47.3%, p=0.0004) and those who had hypertension (52.6% vs. 47.2%, p=0.05). They were statistically more frequently subjects in the lowest cognitive performances class (<25 th percentile of the distribution) for MMSE ChromSystems internal controls are analyzed in every series of measurements (one control every 10 unknown serums) and in the SFVB quality assurance programmes. The limits of detection were calculated as 5 fold the maximum baseline noise in the region of the peaks.
Hence we found limits of detection of 0.05 µM for retinol, and 0.02 µM for carotenoid. All concentrations of retinol, lycopene and β-carotene were above these respective limits, while only 5% of lutein, 8% of zeaxanthin, 2% of β-cryptoxanthin were under.
Total plasma carotenoids levels were obtained by summing levels of lutein, zeaxanthin, β-cryptoxanthin, lycopene, α and β-carotenes.
Questionnaire and medical examination
The general questionnaire allowed us to obtain information on socio-demographic factors such as sex, age, educational achievement, plus consumption habits like tobacco status, alcohol consumption (which was determined from the subject's estimated average amount of alcoholic beverages ingested weekly) and medication use. In addition, height and weight were measured. Two independent measures of systolic and diastolic blood pressure were made with a digital electronic tensiometer after a 10-minute rest. Total plasma cholesterol, and plasma glucose levels were also measured using routine methods. The apolipoprotein E genotype of subjects was determined on DNA samples.
Statistical Methods
The characteristics of the 589 subjects included in the analysis were described compared to the 184 subjects who had blood sampling but not the cognitive evaluation at EVA6, results were expressed by percentage and means with their standard deviation (SD).
To test the differences between these two groups, Chi square test and the Student T test were To calculate the correlation between carotenoids, we calculated Pearson correlation coefficients on log transformed carotenoids. Table 2 .
Classical multivariate logistic regressions were performed to test associations between probability of subjects to have the lowest cognitive functioning and levels of plasma carotenoids (<25 th percentile vs. >25 th percentile) adjusting on all potential confounding variables. Results were expressed by odds ratios (OR) with their 95% confidence intervals (CI). All interactions between each carotenoid and each consumption habits and health variables were calculated and were not statistically significant. Statistical analyses were performed using SAS software version 9.1 (SAS Institute, Inc. Cary, North Carolina).
Results
Characteristics of the 589 EVA subjects (Table1)
The 589 subjects of EVA study (361 women and 228 men, aged 73.5 2.9), on which,
we carried the analysis, were well educated (52.1% had a high school or superior degree).
Among them, 39.0% were smokers or ex-smokers, 24% consumed alcohol regularly (2glass/day). For the repartition of subjects between BMI classes, we observed 13.8% of We also compared the characteristics of these 589 subjects included in the analysis to the 184 subjects for which we only obtained a blood sample but not a cognitive evaluation.
Results showed that these 184 subjects were significantly older (74.23.1 vs. 73.5 2.9),
proportions of subjects with hypertension (p=0.05) or with a history of cardiovascular diseases (p=0.03) were higher. On the other hand, proportions of subjects with low levels in -cryptoxanthin, trans and cis -carotene were significantly lower in this group (results not showed).
Description of carotenoids: correlation and associated factors
Plasma carotenoids were highly and significantly inter-correlated. The highest correlations were found among carotenes: -carotene/ trans-carotene (r=0.78), trans-carotene/ cis -carotene (r=0.61), -carotene/ lycopene (r=0.60) and among lutein/ zeaxanthin (r=0.58). The other correlation coefficients ranged from 0.16 for lycopene/ -cryptoxanthin to 0.50 for trans-carotene/ lycopene.
In Table 3a and 3b, we describe the characteristics of subjects according to their total plasma carotenoid, the different xanthophylls and carotenes levels (<25 th percentile vs.  25th percentile). We observe that the profile of factors associated to -carotene, trans-carotene and cis -carotene were identical. Between the other carotenoids, however, the associated factors can differ. Gender was associated to all carotenoids, which reach higher levels in women with the exception of zeaxanthin. Tobacco status and alcohol consumption were significantly associated to lower levels for total plasma carotenoids, -cryptoxanthin, -carotene, trans and cis -carotene. Diabetes was associated to low levels of all carotenoids, while hypertension were significantly associated to low levels of lutein, -carotene, trans and cis -carotene. Obesity and overweight were associated to low levels of all carotenoids excepted for zeaxanthin and -cryptoxanthin. Age, education, depressive symptomatology, dylipidemia, history of cardio-vascular diseases and apolipoprotein E genotype were not associated with any plasma carotenoids. 
Association between cognition and carotenoids
Sensitivity analysis
The same analyses were first performed, by removing subjects with depressive symptomatology (n=49), then by removing subjects who were underweight (BMI<21kg/m²) (n=81) and thirdly by adjusting on levels of plasma retinol. In the three situations, we obtained similar results. We also performed analyses on subjects who had a MMSE score  25 (n=570), to exclude subjects with potential clinically significant cognitive impairment (n=19). Results were identical (data not showed).
On the other hand, we performed models which explain the probability to have cognitive tests scores <10 th percentile of the distribution scores for the different plasma carotenoids levels. Only associations between zeaxanthin and FTT (p=0.003) and TMTB (p=0.06), and lycopene and DSS (p=0.07) remained marginally statistically significant (data not showed). In these analyses, the number of subjects, which had the lowest cognitive performances was 2.2 to 2.8 smaller than for the precedent analyses (n=54 for MMSE, 49 for DSS, 55 for TMTA, 53 for TMTB, 52 for FTT and 38 for the TEL). It comes from a lack of statistical power, which could explain the drop in statistically significant results.
All our analyses were conducted with dichotomized variables for both the plasma carotenoids and the cognitive outcomes; in supplemental analyses, we tested if similar findings were observed when a continuous measure for cognition was used. We calculated Spearman correlation coefficients between cognitive variables and log-transformed carotenoids. Results showed a significant association for zeaxanthin and lycopene and DSS (r=0.08, p=0.01 and r=0.11, p=0.006 for zeaxanthin and lycopene respectively), TMTA (r=-0.11, p=0.01 and r=-0.08, p=0.05), TMTB (r=-0.08, p=0.05 and r=-0.12, p=0.004) and FTT (r=0.09 p=0.04 and r=0.09 p=0.04). These correlations confirm that our findings were not driven by the chosen dichotomous classifications for cognition and carotenoids levels.
Discussion
To our knowledge, this study is the first one, which investigated, in a healthy elderly population, the relation between cognitive performances measured by five neuropsychological tests and the different plasma carotenoids: xanthophylls (lutein, zeaxanthin, β-cryptoxanthin) and carotenes (lycopene, α-carotene, trans β-carotene and cis β-carotene).
The EVA study included volunteers with higher educational status, higher incomes and greater cognitive function than the average elderly French population. Despite this selection, plasma carotenoids concentrations in the EVA study population were in the same ranges as those in different European or American populations (4) . In this present study low levels of specific plasma carotenoids -lycopene and zeaxanthin-were associated to poor cognitive functioning in a highly educated free-living elderly community.
Carotenoids are found in coloured fruits and vegetables. Some studies showed that plasma carotenoids levels could be related to dietary fruits and vegetables intake (25, 26) .
More specifically, it seems that mango, papaya, peaches, prune, squash, orange, green fruits and vegetables were source of zeaxanthin, while tomatoes, pink grapefruit, and watermelon are sources of lycopene (3). Two cross sectional studies (27, 28) showed an association between greater intake of fruits and vegetables and better cognitive performances. In a large prospective study of older women (n=13388) (29) , the authors reported relation between low vegetables intake and cognitive decline but no relation with fruits, the strongest association being with greater intake of green leafy vegetables and cruciferous vegetables. Even if some studies show that intakes of foods with high carotenoid contents were correlated with their corresponding plasma concentrations (26) , intake of fruits and vegetables are sources of many other nutrients which have been associated to cognitive functions : vitamin E (30), folates (31, 32) , flavonoids (33) . It is now impossible to know if the association between carotenoids and cognitive functions is the results of a specific effect of carotenoids or if it is the resultant of combined effects of the different fruits and vegetables compounds.
For each cognitive test, we tested eight-association hypothesis (Ho) between cognitive functions and carotenoids. In order to ensure that significant observed associations were not hazard related (alpha risk=5%), specific multiple test (Bonferroni, Sidak) corrections were applied to data. Considering, however, that the tested hypothesis are not independent, submitting them to these corrections entails an overcorrection of threshold significance thus not necessarily leading to rejection of the Ho hypothesis, which we know to be false. In this exploratory analysis, the fact that one specific carotenoid was associated to more than one cognitive function, and that these associations remained statistically significant after controlling on potential confounding factors, or after removing some subjects (subjects with depressive symptomatology, subjects with a MMSE score <25 or undernourished subjects) seems to us more likely to ensure that our significant observed associations were not hazard related.
Although there were important correlations among all carotenoids, we observed significant associations of low cognitive performances with some but not all carotenoids.
More specifically, we found no associations between β-carotenes (trans or cis) or α-carotene, which are the most studied carotenoids in epidemiological literature on cognitive impairment (5) (6) (7) (8) (9) (10) (11) . These studies give conflicting results. Previously, in the EVA study, we showed that a low level of baseline total plasma β-carotene (<25 th percentile) was not significantly associated to a 4-year cognitive decline (5). In a cross-sectional study, Perrig et al. (9) showed that a higher β-carotene plasma level was associated to better memory performances (free recall, recognition and vocabulary) in 442 healthy persons aged 65 to 94. Studying dietary intake of β-carotene, Morris et al. (8) found no association between carotene intake and cognitive decline, while the Rotterdam Study showed that a lower intake of β-carotene was associated with impaired cognitive function measured by MMSE (7) . Three studies investigated the link between cognitive performances and supplementation of antioxidants including β-carotene (6, 10, 11). All, except the work of the Age-Related Eye Diseases Study
Research Group (11) , found that use of these supplements reduced the risk of cognitive decline. In these studies with multi-antioxidant supplementation it is, however, impossible to isolate the specific effect of β-carotene on cognitive impairment. Only one study, concerning 1769 subjects, focused on the association of a large spectrum of carotenoids and cognitive performances in elderly subjects without neuropsychiatric disease, but it found no association (34) . Discrepancies can be explained by methodological differences (neuropsychological tests to assess cognitive performances, number of tests used, choice of modelling of carotenoids…). Finally we found two clinical epidemiological studies (35, 36) which focused on the comparison of plasma carotenoids and retinol levels in elderly patients with or without Alzheimer disease (AD). One showed that levels of vitamin A, lutein, zeaxanthin, β-cryptoxanthin and α-carotene were lower in AD patients (n=63) than controls (n=56).
However, they found no difference for lycopene and β-carotene (36) . In the second study, levels of carotenoids were lower in AD patients (n=40) than in controls (n=39) for zeaxanthin, β-cryptoxanthin, lycopene and β-carotene but not for lutein and α-carotene (35) . These conflicting results could be explained by the limited sample size of these studies. The major problem for interpreting these two studies is that they are studying AD cases for which nutritional habits, and consequently, biological status, can be modified, as a consequence of the disease progression. The different measurement methods and the bioavailability of carotenoids, which is influenced by several factors such as characteristics of the food sources, interactions with other dietary factors and various subject characteristics (3) could also explain the differences between studies.
Many epidemiological studies have associated high carotenoid status with a decrease in the incidence of chronic diseases (heart diseases and cancer), the biological mechanism for such protection is, however, currently unclear (3). Multiple possibilities exist, amongst them, certain carotenoids can be converted to retinoid and have a pro-vitamin A activity. To assess if the relation we showed could be explained partly by this hypothesis, we adjusted our models on retinol concentration, but results remained unchanged.
Our results are supported by those of a biological study on oxidation of carotenoids by free radicals led by Woodall et al (37) , which found that lycopene, lutein and zeaxanthin all reacted rapidly with oxidising agents and must also be considered as potential dietary antioxidants. A possible explanation for low levels of plasma carotenoids in AD or cognitive impairment is that they might be consumed because of higher rate of free radical production in the brain.
Our results on the relation between carotenoids and cognitive performances were not modified when we excluded the subjects with BMI <21 kg/m² for which the hypothesis of under nutrition is probable. This allows us to say that this relation could not be limited to the influence of undernourished subjects. However, in this cross sectional frame-work, it is not possible to affirm if these low levels of carotenoids preceded or were the consequence of cognitive impairment in a context where poor cognitive status may be a risk factor for poor nutrition. In this study, we used various tests to explore cognitive performances and this approach is more powerful than using only MMSE, which is not a very sensitive measurement of cognitive impairment. With the other tests, the psychometric scores ranges are large and more powerful to study cognitive impairment. Beside, because the scores were not normally distributed, a percentual cut-off is appropriate. The observed association will probably have no functional significance yet, because participants had only a subtle impairment. Moreover, we have no basis to expect specific association between carotenoids and psychometric evaluation. However, it is well known, that low plasma lutein and zeaxanthin concentrations were implicated in the age-related macular degeneration (38) . While retina is a puzzle whose ultimate solution lies on the other side of the optic nerve in its connection with the brain, a highly specific accumulation of lutein and zeaxanthin in the retina and in the macula is described (39 th percentile) *Mean  SD for age and BMI Table 4 : Crude risk of low cognitive functioning (score <25 th ) associated to plasma carotenoids for each cognitive test. * Odds Ratio, with their confident interval at 95 %, of probability of subject to have the lowest cognitive functioning associated to each plasma carotenoid level. Table 5 : Adjusted risk of low cognitive functioning (score <25 th ) associated to plasma carotenoids for each cognitive test. * Odds Ratio, with their confident interval at 95 %, of probability of subject to have the lowest cognitive functioning associated to each plasma carotenoid level, adjusted on sociodemographic factors (sex, age and education, consumption habits (tobacco status, alcohol consumption, medicine use) and health variables (BMI classes, diabetes and hypertension).
